Announcing the first enterprise intervention platform for metabolic disease prevention and reversal. Read press release here.
Company

Together, Solving the Metabolic Problem at Scale.

Journeys Metabolic™ is a pioneer in the development of physician-led metabolic disease interventions for health systems, providers, and patients.

Precision Patient Journey

Long-Term 
Behavior Change

Fully
Interoperable

Mission

We are driven to be the conduit to end the metabolic crisis at scale.

Vision

Empower patients and their providers to enhance care and optimize value-based outcomes with the ultimate goal of transforming the quality of life for all.

Our vision is access to scalable, long-term metabolic health gains for all communities, especially underserved groups that may have received little to no support up to this point.

Leadership Team

Our leadership team includes experienced healthcare executives, metabolic health providers, and clinical experts dedicated to making an impact on the metabolic crisis.

Jim Howard

CEO & CoFounder

Jim Howard is a 29-year healthtech executive and founder of Journeys Metabolic in 2023 after four years as cofounder and CEO of legacy company Readout Health, raising launch capital and incubating the project as an EIR with Biogenerator Ventures in St. Louis. Prior to Readout Health, Jim cofounded and was the initial CEO of Washington University-spinout SentiAR, the first AR platform for interventional procedures. He previously led a team of 50 as a commercial VP of at CareFusion’s through the acquisition by Becton Dickinson in 2015. Jim was a first-five employee and VP of Global Sales at digital health startup Pharmacy OneSource, acquired by Wolters Kluwer Health in 2010. He is a board director at POC medical device company, MagBiosense, and is passionate about metabolic disease reversal for both clinical and financial implications.
Read Bio

Kelly Matthew

Head of Clinical Program Development

Kelly is head of metabolic solution development and cofounder of Journeys Metabolic. She cofounded Well-Being with Dr. Allison Hull and co-created the successful intervention 12-week metabolic disease reversal program. For over twenty years, Kelly’s work in the field of Health & Wellness has included program design, development, implementation, and clinical research at Johnson & Johnson, BayCare Health System, and Florida Medical Clinic.

Prior to Journeys Metabolic, Kelly was Co-Founder of Well-Being a Tribe Planted with Purpose a DTC 12-week Metabolic Health Program. As a certified Intrinsic Health Coach, Kelly believes in taking a “whole person” approach to health and empowering individuals to participate actively in their lifelong wellness journey.

Read Bio

Nichole DiLoretta

Head of Operations

Nichole is a 17-year Operations and Quality executive with leadership experience in highly regulated industries including roles at bioMerieux and Pfizer Pharmaceuticals. Her most recent role was VP of Operations at Infinity Labs. As a scientist and executive professional, her background in lab and manufacturing practices, microbiology, chemistry, and method development ensures adherence to quality and regulatory processes at Journeys Metabolic, including developing and maintaining QMS and operational excellence initiatives. Nichole is passionate about bringing those standards and initiatives into the healthcare space to ensure best practices and proven outcomes.

Read Bio

Greg Robinson, PhD

Chief Technology Officer

Greg Robinson, PhD is our CTO at Journey'sMetabolic and is passionate about value-based healthcare and improving the lives of patients in need. He most recently led AI product development, technology, and data operations at Relias, with a focus on products for clinicians and health systems. Prior to that role, he was the Chief Data and Analytics Officer for Marshfield Clinic Health System, responsible for the development of strategy and tactical execution of data as an asset for the Marshfield Clinic Health System. Greg was co-founder of a health IT software in the predictive modeling space and has held senior executive and consultant roles leading technology and operations for healthcare organizations for academic medical centers and health plans. He holds a PhD from the University of California at Berkeley and is an active auto enthusiast and racer.

Read Bio

Steve Edwards

Chief Strategy Officer

Steve Edwards serves as the Chief Strategy Officer at Journeys Metabolic after three decades of acute care leadership. He is passionately focused on transforming the traditional model of healthcare toward prevention through innovative technology and virtual platforms.

Steve retired from CoxHealth after 30 years of service where he held a multitude of leadership roles, culminating in his decade-long tenure as President and CEO of the $1.9 B Missouri-based health system.

While President at CoxHealth, Steve shepherded the health system through a period of significant growth and transformation, enlarging the employee base from 7,500 to 12,500, adding hospitals, clinics and insurance companies. Under his leadership CoxHealth won distinctions for quality, economic development, information technology, nursing care and employee satisfaction. The organization has been recognized five consecutive years by Forbes Magazine as a leading place to work. CoxHealth made huge swings in market share and sharply increased its profitability, liquidity and balance sheet during Steve’s tenure.

Steve completed a post graduate fellowship at Baylor University Medical Center, holds a Masters of Health Administration from the Washington University School of Medicine, and a B.S. from Drury University.

Read Bio

David Mait

Head of Marketing

David is our Head of Marketing at Journeys Metabolic. Over his 15+ years as a senior healthcare marketer, he has helped fast-growing digital health companies level-up their marketing function + team, accelerate growth pipeline, and communicate their brand story + offerings to prospects, customers and the world.

David formerly held lead marketing roles at Heartbeat Health (virtual cardiology), Quartet Health (behavioral health) and Castlight Health (healthcare transparency). In addition to healthcare, he has acted as a Fractional Chief Marketing Officer for a diverse set of B2B and B2C venture-backed software companies. David completed his Masters in International Relations at the Maxwell School of Citizenship at Syracuse University and his BA at Lehigh University. He loves being outdoors and is a passionate Miami Dolphins and A.S. Roma fan.

Read Bio

Advisors

We are advised by cutting-edge thinkers in metabolic and population health from some of the world's leading institutions.

Robert Lustig, MD

UCSF
Neuroendocrinologist

Dr. John Mattison, MD 

Former Kaiser
Permanente CMIO

Open Positions

5+ Years of Data

Clinical Outcomes

At Journeys Metabolic™, we offer an intervention protocol backed by more than 5 years of clinical data showing long-lasting results. Our physician-developed program has helped thousands of patients lose weight, manage their blood glucose, and lower their blood pressure through easy-to-use technology. 

In our clinical trial, we saw significant improvements in depression, anxiety and sleep quality through standardized, evidence-based assessments, PHQ-9, GAD-7, and PSQI respectively.
8
%
 Body Weight Reduction
17
%
HbA1c Reduction
8
%
Systolic Blood Pressure Reduction
30
%
Triglyceride Reduction
54
%
NAFLD Resolution
8
%
Average Weight Loss
Over a five-year period, Journeys Metabolic™ assisted patients in reducing their weight through long-term behavior change.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
17
%
HbA1c Reduction
Journeys Metabolic™ has helped patients systematically lower their blood glucose levels over the course of a five-year period.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
8
%
Systolic Blood Pressure Reduction
Through the Journeys Metabolic™ program, patients have been able to reduce their systolic blood pressure over the past five years.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
30
%
Triglyceride Reduction
Triglyceride levels among Journeys Metabolic™patients have dropped significantly over a five-year period.

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
54
%
NAFLD Resolution
Over a five-year period, Journeys Metabolic™ achieved remarkable success in facilitating NAFLD resolution through comprehensive lifestyle modifications and sustainable behavioral changes.


Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”

Alex Bern

“Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard.”
Research & Insights

The Journeys Blog

Access the latest insights, research, and updates on metabolic health at our Journeys Blog.

The Link Between Insulin Resistance and Weight: How to Break the Cycle

If you’ve ever tried to lose weight, you’ve probably heard the advice to eat less and move more. You may have also heard that weight loss is simply […]
Read More
Font Size
crosschevron-downchevron-leftchevron-right linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram